Clinical profile of mumps in children in a tertiary care hospital in Kashmir

Authors

  • Ummer M. Bhat Department of Pediatrics, Government Medical College Srinagar, Jammu and Kashmir, India
  • Naseer Yousuf Mir Department of Pediatrics, Government Medical College Srinagar, Jammu and Kashmir, India
  • Wamiq Farooq Department of Pediatrics, Government Medical College Srinagar, Jammu and Kashmir, India
  • Bashir U. Zaman Department of Pediatrics, Government Medical College Srinagar, Jammu and Kashmir, India
  • Mohammad Imran Malik Department of Pediatrics, Government Medical College Srinagar, Jammu and Kashmir, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20230421

Keywords:

Socioeconomic, Salivary glands, Immunization

Abstract

Background Mumps is one of the oldest human illnesses known to humans. Mumps is caused by a paramyxovirus, which is a single-strand RNA virus. Mumps is characterized by painful, unilateral, or bilateral swelling of the salivary glands, in particular, the parotid glands.

Methods: This is a hospital-based prospective observational study. All children of age ≤18 years, both males and females with acute onset of unilateral or bilateral tender, self-limited swelling of the parotid or other salivary gland without other apparent cause.

Results: Of the 150 clinically diagnosed mumps cases, 87 (58%) were male and 63 (42%) were female (male-to-female ratio of 1.4:1). There was no case below 1 year but there were 40 cases between 1 and 5 years. The 40% belonged to the lower middle class of socioeconomic status as per Kuppuswamy’s scale, followed by the upper-middle and lower-middle class. Only 15 patients (10%) were completely immunized whereas the immunization status of 8% patients was not known, and the rest of the patients were non immunized (82%). Fever was the most common presentation (150 patients;100%), followed by parotid involvement. Parotitis was present in 146 (97.3%) cases at some point during the illness, 36 patients (24%) had unilateral and 110 patients (73.3%) had bilateral involvement. 16% of patients had multiple salivary gland involvement. Mean duration of illness was 9.0±2 days.

Conclusions: Mumps is a significant public health problem to warrant investment in prevention through vaccination.

References

Rubin S, Kennedy R, Poland G. Emerging mumps infection. Pediatr Infect Dis J. 2016;35(7):799-801.

Tyor W, Harrison T. Chapter 28: Mumps and rubella. Handbook Clin Neurol. 2014;123:591-600.

Centers for Disease Control and Prevention. Mumps cases and outbreaks. 2017. Available at: http://www.cdc.gov/mumps/outbreaks.html. Accessed on March 24, 2017.

McLean HQ, Fibelkorn AP, Temte JE, Wallas GS. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). Center for Disease Control and Prevention Recommendations and Reports. 2013;62(RR04):1-34.

Caserta MT. 2014. Mumps (epidemic parotitis). Merck Manual Professional Version. Available at: http://www.merckmanuals.com/professional/pediatrics/miscellaneous-viral-infections-in-infants-and-children/ mumps#v102306. Accessed on March 6, 2022.

Reichmann ME. Animal virus. Access Science. 2014.

Fiebelkorn A, Barskey A, Hickman C, Bellini W. Chapter 9: Mumps. VPD Surveillanc Manual, 5th ed. 2012.

Vaccines. Available at: https://www.cdc.gov/ vaccines/pubs/surv-manual/chpt09-mumps.pdf. Accessed on March 14, 2022.

Office of Disease Prevention and Health Promotion. IID-1.5 Reduce cases of mumps (U.S.-acquired cases). 2017.

The Healthy People 2020. Available at: https://www.healthypeople.gov/2020/topics-objectives/objective/iid- 15-0. Accessed on March 14, 2022.

Latner DR, Hickman CJ. Remembering mumps: E1004791. PLoS Pathogens. 2015;11(5).

Rubin S, Eckhaus M, Rennick L, Bamford C, Duprex W. Molecular biology, pathogenesis and pathology of mumps virus. J Pathol. 2015;235:242-52.

World Health Organization. Mumps virus nomenclature update: 2012. Available at: http:// www.who.int/wer/2012/wer8722/en/. Accessed on March 14, 2022.

Centers for Disease Control and Prevention. Mumps: For healthcare providers, 2016. Available at: https://www.cdc.gov/vaccines/vpd/mmr/public/index.html#what-is-mmr. Accessed on January 5, 2023.

Van Panhuis W, Grefenstette J, Jung S. Contagious diseases in the United States from 1888 to the present. New Engl J Med. 2013;369(22):2152-8.

Zamir C, Schroeder H, Shoob H, Abramson N, Zentner G. Characteristics of a large mumps outbreak: clinical severity, complications and association with vaccination status of mumps outbreak cases. Hum Vaccin Immunother. 2015;11(6):1413-7.

Fiebelkorn A, Coleman L, Belongia E. Measles and mumps antibody response in young adults after a third dose of measles- mumps-rubella vaccine. Open Forum Infect Dis. 2014;1(1): S58.

Arkansas Department of Health. Mumps. Available at: http://www.healthy.arkansas.gov/programs Services/infectiousDisease/CommunicableDisease/Pages/Mumps.aspx. Accessed on March 24, 2022.

Burns C, Dunn AM, Brady MA, Starr NB, Blosser CG, Garzon DL. Pediatr Primary Care. 6th ed. Philadelphia, PA: Elsevier. 2017.

Raut SK, Kulkarni PS, Phadke MA, Jadhav SS, Dhorje SP. Persistence of Antibodies Induced by Measles-Mumps-Rubella Vaccine in Children in India? Clin Vaccine Immunol. 2007;14(10):1370-71.

Gupta RK, Jennifer Bt, MacMahon E. Mumps and the UK epidemic. 2005;2005;330.

Bernard H, Schwarz NG, Melnic A, Bucov V, Caterinciuc N, Pebody RG et al. Mumps outbreak ongoing since october 2007 in the republic of Moldova. Euro surveillance. 2008;13(13):8.

Peltola H, Prasad SK, Subhash VK, Mikko P, Suresh SJ, Rajeev MD. Mumps Outbreaks in Canada and the United States: Time for New Thinking on Mumps Vaccines. Clin Infect Dis. 2007;45(4):459-66.

Moghe CS, Goel P, Singh J. Mumps outbreak investigation in Jaisalmer, Rajasthan, India, June-September 2016. J Med Virol. 2019;91(3):347-50.

Arshad AS, Shamila H, Khan I, Syed MA. Patterns of mini-outbreaks of mumps at South Kashmir, Pulwama, India 2007-2011. Nitte University J Heal Sci. 2013;3:52-5.

Sharma J. Surveillance of Mumps Cases in Lakhimpur District, Assam and Importance of MMR Vaccine. American Journal of Drug Delivery and Therapeutics. AJDDT. 2015;2(1):016-9.

John TJ. An outbreak of mumps in Thiruvananthapuram district. Indian Pediatr. 2004;41(3):298-300.

Gupta M, Tripathy JP, Verma M, Singh MP, Kaur R, Ratho RK et al. Seroprevalence of measles, mumps and rubella antibodies among 5-10 years old children in north India. Indian J Med Res. 2019;149:396-403.

Bakker W, Mathias R. Mumps caused by an inadequately attenuated measles, mumps and rubella vaccine. Can J Infect Dis. 2001;12(3):144-8.

Saha I, Haldar D, Paul B, Shrivastava P, Das DK, Pal M et al. An epidemiological investigation of mumps outbreak in a slum of Kolkata. J Commun Dis. 2012;44(1):29-36.

Downloads

Published

2023-02-23

Issue

Section

Original Research Articles